PeptiDream Inc. Logo

PeptiDream Inc.

Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.

4587 | T

Overview

Corporate Details

ISIN(s):
JP3836750004
LEI:
Country:
Japan
Address:
川崎市川崎区殿町三丁目25番23号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

PeptiDream Inc. is a biopharmaceutical company specializing in the discovery and development of innovative peptide-based therapeutics. The company leverages its proprietary Peptide Discovery Platform System (PDPS) to rapidly identify and generate novel macrocyclic peptides against a wide array of therapeutic targets. Operating as a "Drug Discovery Powerhouse," PeptiDream collaborates with pharmaceutical partners worldwide to advance new medicines through preclinical research, utilizing its expertise in discovery biology, medicinal chemistry, and pharmacological profiling. Additionally, through its wholly-owned subsidiary PDRadiopharma, the company markets and sells a portfolio of approved radiopharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 08:50
Interim Report
確認書
Japanese 8.9 KB
2025-08-07 08:49
Interim Report
半期報告書-第20期(2025/01/01-2025/12/31)
Japanese 786.2 KB
2025-03-28 08:48
Governance Information
内部統制報告書-第19期(2024/01/01-2024/12/31)
Japanese 23.4 KB
2025-03-28 08:47
Annual Report
有価証券報告書-第19期(2024/01/01-2024/12/31)
Japanese 3.2 MB
2025-03-28 08:47
Registration Form
確認書
Japanese 8.9 KB
2025-03-28 08:45
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-09-25 09:45
Registration Form
確認書
Japanese 8.9 KB
2024-09-25 09:35
Annual Report
訂正有価証券報告書-第18期(2023/01/01-2023/12/31)
Japanese 1.4 MB
2024-08-09 08:29
Interim Report
確認書
Japanese 8.9 KB
2024-08-09 08:28
Interim Report
半期報告書-第19期(2024/01/01-2024/12/31)
Japanese 650.4 KB
2024-05-15 08:31
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-05-15 08:30
Quarterly Report
四半期報告書-第19期第1四半期(2024/01/01-2024/03/31)
Japanese 540.7 KB
2024-04-01 08:30
Registration Form
有価証券届出書(参照方式)
Japanese 95.3 KB
2024-03-28 07:53
Declaration of Voting Results & Voting Rights Announcements
臨時報告書
Japanese 22.4 KB
2024-03-28 07:40
Registration Form
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all PeptiDream Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PeptiDream Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PeptiDream Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea
230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050

Talk to a Data Expert

Have a question? We'll get back to you promptly.